Tempus Is Eric Lefkofsky’s Latest Philanthropic Project And Company

The medical industry is always improving and finding new ways to help people with their problems. Out of all the medical problems people can find themselves dealing with cancer is typically one of the worst ones. This is not only because of what it does to the body and how painful it can be, but because there is no specific cure. Eric Lefkofsky is a businessman and entrepreneur that has found success in various different companies today, including Tempus, which is focused on compiling data related to cancer from all over the world. Despite the ever-advancing industry, Eric saw up close that the medical field was lacking in terms of technology when it came to their ability to sort and structure data.

Eric Lefkofsky co-founded Tempus with a longtime friend, Brad Keywell, and the company currently resides in Chicago. As the CEO of Tempus, Eric Lefkofsky has big plans for the company and its research. Eric has personally invested millions into this company to ensure its success. By compiling molecular and genomic data from patient files around the world, Tempus will be able to provide doctors with all the information and notes they could need to personalize their treatment for each cancer patient. While this does not specifically fight cancer, it allows medical practitioners to fight it to the best of their ability for everyone that is afflicted.

Tempus is a new idea for Eric Lefkofsky, but his generosity and desire to help others has been a longtime commitment for him. Eric and his wife founded and run their own charitable foundation that works to help gives students a better education all over the country. Various programs at Eric’s foundation help students get into all sorts of industries today, including medical, art, history, and even human rights. At the end of the day, almost everything Eric works to achieve is also work towards helping others and creating a better global community.

Read More: www.crunchbase.com/person/eric-lefkofsky

You Might Also Like